Hi there!
We track 70,000+ AI startups and surface hidden job opportunities that never appear on LinkedIn. Tell us what you're looking for, our AI agent does the searching. It's free and you sign up using Google. Go explore!
UbiVac
UbiVac is a clinical-stage immunotherapy company pioneering "Dark Genome-derived" cancer immunotherapies, with its lead agent DPV-001 targeting "Cancer's Dark Matter" – newly discovered non-mutated…
UbiVac
UbiVac is a clinical-stage immunotherapy company pioneering "Dark Genome-derived" cancer immunotherapies, with its lead agent DPV-001 targeting "Cancer's Dark Matter" – newly discovered non-mutated…
TL;DR
Stage: Clinical-stage immuno-oncology company
Lead product: DPV-001 (DRibble) — off-the-shelf dendritic-cell–targeted cancer vaccine
Founded: 2005
Technology: Dark Genome–derived cancer immunotherapies; machine learning/AI for target discovery
Manufacturing: In-house GMP manufacturing capabilities
Company Overview
Problem Domain
Cancer immunotherapy; discovery of shared alternative neoantigens ('Cancer's Dark Matter') to broaden immune targeting across tumors.
Founded
2005
Industry
Biotechnology
Tech Stack
Funding Track Record
250000
Recorded April 2022 (Dealroom lists ~ $250k for April 2022)
Founders
What we do
Join the Team
Startup jobs. A lot of them.
Your next opportunity is in here somewhere. Sign up to explore 70,000+ startups and their open roles. No spam. No gamification. Just jobs.
70,000+
Startups
83,000+
Open Roles
4,600+
New This Week